List of insiders holdings for Kyverna Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Vida Ventures LLC Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner |
2024-05-03 17:57:02 | 4,777,060 0 |
4,777,060 | Form 13D |
| 2 | Cohen Fred E Director 10% Owner |
2024-02-14 19:03:04 | 0 4,523,924 |
4,523,924 | Form 4 |
| 3 | Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC Harper Sean E 10% Owner |
2024-11-12 07:23:31 | 4,523,924 0 |
4,523,924 | Form 13G |
| 4 | GILEAD SCIENCES INC. 10% Owner |
2024-02-20 16:31:04 | 4,126,119 0 |
4,126,119 | Form 13G |
| 5 | Northpond Ventures III GP LLC Northpond Ventures III LP Rubin Michael P. Former 10% Owner |
2024-02-22 16:29:57 | 3,255,426 0 |
3,255,426 | Form 13G |
| 6 | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences III General Partner LLC Bain Capital Life Sciences Fund III L.P. Bain Capital Life Sciences Opportunities III GP LLC Bain Capital Life Sciences Opportunities III LP 10% Owner |
2024-02-14 17:26:31 | 0 3,163,868 |
3,163,868 | Form 4 |
| 7 | Maag Peter Chief Executive Officer |
2024-02-07 21:55:36 | 1,378,651 349,321 |
1,727,972 | Form 3 |
| 8 | SEIDENBERG BETH C Director 10% Owner |
2024-02-14 18:56:43 | 0 735,984 |
735,984 | Form 4 |
| 9 | Borie Dominique Christian See Remarks |
2024-02-07 21:58:49 | 113,420 449,210 |
562,630 | Form 3 |
| 10 | GEHCHAN NAJI See Remarks |
2025-01-24 20:05:04 | 425,000 0 |
425,000 | Form 4 |
| 11 | CLARK IAN T Director |
2024-02-07 21:58:25 | 364,398 0 |
364,398 | Form 3 |
| 12 | Biddle Warner Weston Chief Executive Officer |
2025-04-15 17:42:51 | 332,500 0 |
332,500 | Form 4 |
| 13 | Chung James Bum Chief Medical Officer |
2024-02-07 21:57:35 | 209,838 0 |
209,838 | Form 3 |
| 14 | Jones Ryan Alexander Chief Financial Officer |
2025-04-15 17:42:36 | 129,950 0 |
129,950 | Form 4 |
| 15 | Walker Karen Marie Chief Technology Officer |
2025-04-15 17:40:15 | 102,636 0 |
102,636 | Form 4 |
| 16 | Aktar Mert Director |
2024-10-24 06:05:19 | 87,741 0 |
87,741 | Form 4 |
| 17 | Kotzin Brian L. Director |
2024-02-07 21:57:10 | 76,265 0 |
76,265 | Form 3 |
| 18 | SPIEGELMAN DANIEL K Director |
2024-02-07 21:58:50 | 50,537 0 |
50,537 | Form 3 |
| 19 | Shaw Christi Director |
2025-02-19 17:55:53 | 38,679 0 |
38,679 | Form 4 |
| 20 | Liapis Stephen Constantine Director |
2024-02-08 06:10:14 | 0 0 |
0 | Form 3 |